Posted on 05/29/2020 9:08:52 AM PDT by SeekAndFind
Oncologist and hematologist Dr. William Grace joins Laura Ingraham with reaction on 'The Ingraham Angle.' ( CLICK ABOVE LINK FOR THE VIDEO ).
See the study here. TITLE:
Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis
Authored by Dr. Harvey Risch at the American Journal of Epidemiology.
Abstract
More than 1.6 million Americans have been infected with SARS-CoV-2 and >10 times that number carry antibodies to it. High-risk patients presenting with progressing symptomatic disease have only hospitalization treatment with its high mortality.
An outpatient treatment that prevents hospitalization is desperately needed. Two candidate medications have been widely discussed: remdesivir, and hydroxychloroquine+azithromycin. Remdesivir has shown mild effectiveness in hospitalized inpatients, but no trials have been registered in outpatients.
Hydroxychloroquine+azithromycin has been widely misrepresented in both clinical reports and public media, and outpatient trials results are not expected until September.
Early outpatient illness is very different than later hospitalized florid disease and the treatments differ. Evidence about use of hydroxychloroquine alone, or of hydroxychloroquine+azithromycin in inpatients, is irrelevant concerning efficacy of the pair in early high-risk outpatient disease.
Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy. Hydroxychloroquine+azithromycin has been used as standard-of-care in more than 300,000 older adults with multicomorbidities, with estimated proportion diagnosed with cardiac arrhythmias attributable to the medications 47/100,000 users, of which estimated mortality is <20%, 9/100,000 users, compared to the 10,000 Americans now dying each week.
These medications need to be widely available and promoted immediately for physicians to prescribe.
(Excerpt) Read more at news.yahoo.com ...
Another study that ignores zinc. And even without that key ingredient it helps.
Forward this to Fox’s Tubby Cavuto. It might make his head explode.
BACKGROUND OF THE AUTHOR OF THE STUDY:
https://medicine.yale.edu/profile/harvey_risch/
Dr. Harvey Risch is Professor of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine.
Dr. Risch received his MD degree from the University of California San Diego and PhD from the University of Chicago. After serving as a postdoctoral fellow in epidemiology at the University of Washington, Dr. Risch was a faculty member in epidemiology and biostatistics at the University of Toronto before coming to Yale.
Dr. Risch’s research interests are in the areas of cancer etiology, prevention and early diagnosis, and in epidemiologic methods. He is especially interested in the effects of reproductive factors, diet, genetic predisposition, histopathologic factors, occupational/environmental/medication exposures, infection and immune functioning in cancer etiology. His major research projects have included studies of ovarian cancer, pancreas cancer, lung cancer, bladder cancer, esophageal and stomach cancer, and of cancers related to usage of oral contraceptives and noncontraceptive estrogens.
Dr. Risch is Associate Editor of the Journal of the National Cancer Institute, Editor of the International Journal of Cancer, and Member of the Board of Editors, the American Journal of Epidemiology. Dr. Risch is an author of more than 300 original research publications in the medical literature, has an h-index of 86, and is a Member of the Connecticut Academy of Sciences and Engineering.
Tubby Cavuto has only air in his head.
Yale = huge credibility in the medical world!
I’ve taken a daily multivitamin for 30+ years. I’m 65.
After 50 same deal except for Adults 50+
But 55+ I’d get the “male over 50” version. All of this just to ensure that I was getting trace minerals and vitamins that might not be picked up in my normal diet.
Along with paper towels and TP vitamin shelves were decimated so the last was just 50+ and below noted 50+ for men - that’s why I had two bottles to compare.
Centrum Silver (50+) had zinc of 11mg for 73% of RDA (Recommended Daily Allowance).
Centrum Silver (MEN 50+) had zinc of 15mg for 136% of RDA (Recommended Daily Allowance).
Since Zelensky views Zinc as crucial and HCQ as the port/facilitator to get Zinc into the cells to actually kill the virus any study not accounting for “normal” vitamin supplementing (and actual zinc levels) may be skewed/useless from the get go (that’s a technical/medical term of art) - means from the start.
;-)
RE: Yale = huge credibility in the medical world!
Depends on the individual doing the research. I wouldn’t go so far as say that Yale has 100% credibility in everything she does. It has to be looked at on a case by case basis.
The ad had as its "catch phrase"..."when Company XYZ talks,people listen".
In the world of medicine the same applies to Harvard...Yale...Columbia....Hopkins...Mayo Clinic...Stanford...and a few others.Of course you can't accept any such statements as gospel...the scientific method demands at least some skepticism.But a paper from Yale Medical School carries more weight than does one from Oklahoma State School of Medicine.
E F Hutton
The evidence is overwhelming if we include Dr Raoult’s findings in France. What does the left have against HCQ? CUomo probably wished he had allowed its distribution in NY homes for the aged.
BTW, the Centrum Men has more D3, and more Zinc, than the 50+ version. I am using that now, as it gives mee 1000 IU of D3, and 100% of my zinc (11 mg).
I’m also taking a D3 pill with magnesium and zinc, but a full dose of 3 pills is only 600 IU, so it’s not nearly as packed as my regular vitamin.
Thanks for finding and posting this!
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.